Skip to content
Application 205625
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ARNUITY ELLIPTA | FLUTICASONE FUROATE | POWDER;INHALATION | 0.1MG/INH | Yes | Yes |
| 002 | ARNUITY ELLIPTA | FLUTICASONE FUROATE | POWDER;INHALATION | 0.2MG/INH | Yes | Yes |
| 003 | ARNUITY ELLIPTA | FLUTICASONE FUROATE | POWDER;INHALATION | 0.05MG/INH | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0173-0874 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0874 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0874 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0874 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0874 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0876 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0876 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0876 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0876 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0876 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0888 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0888 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0888 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0888 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0888 | Arnuity Ellipta | fluticasone furoate | GlaxoSmithKline LLC | NDA | Current |